Sabah Boudjemaa

47-83, Boulevard De L'Hôpital, 75651 Paris Cedex 13
Paris, 75651, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

Journal: Blood advances

Published: January 16, 2026

EuroNet-PHL-LP1: complete resection or low-dose chemotherapy for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

EuroNet-PHL-LP1: complete resection or low-dose chemotherapy for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

Journal: Blood advances

Published: January 16, 2026

Case #1. Thoracic tumour in infants and cancer predisposition syndrome

Case #1. Thoracic tumour in infants and cancer predisposition syndrome

Journal: Annales de pathologie

Published: November 24, 2025

Integration of circulating tumor DNA profiling in the risk stratification of classical Hodgkin lymphoma in children, adolescents, and young adults.

Integration of circulating tumor DNA profiling in the risk stratification of classical Hodgkin lymphoma in children, adolescents, and young adults.

Journal: HemaSphere

Published: September 12, 2025

Efficacy of immune checkpoint inhibitors in paediatric, adolescent and young adults with primary refractory or relapsed classical Hodgkin lymphoma: A national multicentre real-world study.

Efficacy of immune checkpoint inhibitors in paediatric, adolescent and young adults with primary refractory or relapsed classical Hodgkin lymphoma: A national multicentre real-world study.

Journal: British journal of haematology

Published: September 12, 2025

An update on the pathology of peripheral neuroblastic tumors

An update on the pathology of peripheral neuroblastic tumors

Journal: Annales de pathologie

Published: March 11, 2025

Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma

Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma

Journal: Bulletin du cancer

Published: January 10, 2023

Molecular and clinicopathologic characterization of pediatric histiocytoses.

Molecular and clinicopathologic characterization of pediatric histiocytoses.

Journal: American journal of hematology

Published: January 06, 2023

Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.

Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.

Journal: The Lancet. Oncology

Published: September 27, 2022

Synchronous occurrence of neuroblastic tumour and exocrine carcinoma of the pancreas in a child.

Synchronous occurrence of neuroblastic tumour and exocrine carcinoma of the pancreas in a child.

Journal: Pathology

Published: August 09, 2022

Epstein-Barr Virus in Childhood and Adolescent Classic Hodgkin Lymphoma in a French Cohort of 301 Patients.

Epstein-Barr Virus in Childhood and Adolescent Classic Hodgkin Lymphoma in a French Cohort of 301 Patients.

Journal: Journal of pediatric hematology/oncology

Published: August 25, 2021

Clinical, pathologic, and molecular features of inflammatory myofibroblastic tumors in children and adolescents.

Clinical, pathologic, and molecular features of inflammatory myofibroblastic tumors in children and adolescents.

Journal: Pediatric blood & cancer

Published: August 04, 2021

Showing 1-12 of 39

Last Updated: 09/26/2026